New Drugs for Non-Small Cell Lung Cancer
Vizimpro (dacomitinib), Lorbrena (lorlatinib)New Drugs for Metastatic Melanoma
Braftovi (encorafenib), Mektovi (binimetinib)New Drugs for Leukemia or Lymphoma
Copiktra (duvelisib), Lumoxiti (moxetumomab pasudotox), Poteligeo (mogamulizumab), Asparlas (calaspargase pegol), Elzonris (tagraxofusp)New Drugs for Acute Myeloid Leukemia
Xospata (gilteritinib), Daurismo (glasdegib), Tibsovo (ivosidenib)Other New Oncology Drugs
Vitrakvi (larotrectinib), Libtayo (cemiplimab), Talzenna (talazoparib), Erleada (apalutamide), Lutathera (lutetium Lu 177-dota-tate), Akynzeo (netupitant/palonosetron)New Drugs for Hematology
Doptelet (avatrombopag), Mulpleta (lusutrombopag), Tavalisse (fostamatinib), Ultomiris (ravulizumab)
Medscape © 2019 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Mary L Windle. FDA Drug Approvals: Oncology and Hematology — Year in Review 2018 - Medscape - Jan 15, 2019.
Comments